NM_000277.3:c.1155C>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP7

This summary comes from the ClinGen Evidence Repository: This c.1155C>G (p.Leu385=) synonymous variant in PAH is not predicted to have a splice-altering consequence. This variant was present at a high frequency of 0.840256 in 1000 genomes and 0.858145 in ExAC. In summary, this variant meets criteria to be classified as a benign for PAH. PAH-specific ACMG/AMP criteria applied: BP7, BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA180265/MONDO:0009861/006

Frequency

Genomes: 𝑓 0.84 ( 53986 hom., cov: 29)
Exomes 𝑓: 0.85 ( 528935 hom. )

Consequence

PAH
NM_000277.3 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: -0.0970

Publications

34 publications found
Variant links:
Genes affected
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
PAH Gene-Disease associations (from GenCC):
  • phenylketonuria
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
  • classic phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • maternal phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild hyperphenylalaninemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mild phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAHNM_000277.3 linkc.1155C>G p.Leu385Leu synonymous_variant Exon 11 of 13 ENST00000553106.6 NP_000268.1 P00439A0A024RBG4
PAHNM_001354304.2 linkc.1155C>G p.Leu385Leu synonymous_variant Exon 12 of 14 NP_001341233.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAHENST00000553106.6 linkc.1155C>G p.Leu385Leu synonymous_variant Exon 11 of 13 1 NM_000277.3 ENSP00000448059.1 P00439

Frequencies

GnomAD3 genomes
AF:
0.842
AC:
127910
AN:
151868
Hom.:
53951
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.804
Gnomad AMI
AF:
0.792
Gnomad AMR
AF:
0.885
Gnomad ASJ
AF:
0.820
Gnomad EAS
AF:
0.840
Gnomad SAS
AF:
0.872
Gnomad FIN
AF:
0.907
Gnomad MID
AF:
0.832
Gnomad NFE
AF:
0.846
Gnomad OTH
AF:
0.844
GnomAD2 exomes
AF:
0.861
AC:
216427
AN:
251268
AF XY:
0.860
show subpopulations
Gnomad AFR exome
AF:
0.799
Gnomad AMR exome
AF:
0.913
Gnomad ASJ exome
AF:
0.822
Gnomad EAS exome
AF:
0.839
Gnomad FIN exome
AF:
0.907
Gnomad NFE exome
AF:
0.847
Gnomad OTH exome
AF:
0.851
GnomAD4 exome
AF:
0.851
AC:
1242694
AN:
1461134
Hom.:
528935
Cov.:
43
AF XY:
0.852
AC XY:
619004
AN XY:
726890
show subpopulations
African (AFR)
AF:
0.802
AC:
26836
AN:
33450
American (AMR)
AF:
0.908
AC:
40567
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.823
AC:
21502
AN:
26130
East Asian (EAS)
AF:
0.846
AC:
33568
AN:
39696
South Asian (SAS)
AF:
0.889
AC:
76662
AN:
86246
European-Finnish (FIN)
AF:
0.910
AC:
48602
AN:
53406
Middle Eastern (MID)
AF:
0.857
AC:
4937
AN:
5762
European-Non Finnish (NFE)
AF:
0.845
AC:
938782
AN:
1111384
Other (OTH)
AF:
0.849
AC:
51238
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
9848
19696
29545
39393
49241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21122
42244
63366
84488
105610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.842
AC:
128004
AN:
151986
Hom.:
53986
Cov.:
29
AF XY:
0.847
AC XY:
62900
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.804
AC:
33295
AN:
41430
American (AMR)
AF:
0.885
AC:
13510
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.820
AC:
2846
AN:
3472
East Asian (EAS)
AF:
0.840
AC:
4325
AN:
5148
South Asian (SAS)
AF:
0.872
AC:
4187
AN:
4802
European-Finnish (FIN)
AF:
0.907
AC:
9597
AN:
10586
Middle Eastern (MID)
AF:
0.844
AC:
248
AN:
294
European-Non Finnish (NFE)
AF:
0.846
AC:
57487
AN:
67966
Other (OTH)
AF:
0.845
AC:
1787
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1020
2040
3059
4079
5099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.839
Hom.:
13908
Bravo
AF:
0.837
EpiCase
AF:
0.834
EpiControl
AF:
0.837

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Phenylketonuria Benign:5
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2022
ClinGen PAH Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

This c.1155C>G (p.Leu385=) synonymous variant in PAH is not predicted to have a splice-altering consequence. This variant was present at a high frequency of 0.840256 in 1000 genomes and 0.858145 in ExAC. In summary, this variant meets criteria to be classified as a benign for PAH. PAH-specific ACMG/AMP criteria applied: BP7, BA1. -

Nov 16, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 16, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
2.2
DANN
Benign
0.60
PhyloP100
-0.097
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772897; hg19: chr12-103237468; COSMIC: COSV108133564; API